4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline is a synthetic intermediate and building block. It serves as a precursor in the synthesis of various agents, including receptor tyrosine kinase (RTK) inhibitors, dual RTK and histone deacetylase (HDAC) inhibitors, and anticancer agents. It can also be used to synthesize EGFR inhibitors, which exhibit antiproliferative activity.
- Used as a synthetic intermediate
- Precursor in the synthesis of RTK inhibitors
- Precursor in the synthesis of dual RTK and HDAC inhibitors
- Precursor in the synthesis of anticancer agents
- Used to synthesize EGFR inhibitors with antiproliferative activity